Table 2.
Comparison Between CTCNegative and CTCPositive Groups
| CTC+ (n=72) | CTC− (n=77) | P | |
|---|---|---|---|
| Age (years) | 63.22±12.10 | 63.16±12.10 | 0.973 |
| Gender (M/F) | 47/25 | 46/31 | 0.486 |
| BMI (kg/m2) | 22.50±3.66 | 22.70±3.11 | 0.716 |
| Stage I | 8 | 34 | 0.000 |
| Stage II | 16 | 19 | |
| Stage III | 36 | 22 | |
| Stage IV | 12 | 2 | |
| CTC count/7.5 mL | 7.75±3.26 | 1.94±0.92 | 0.000 |
| CEA (ng/mL) | 19.04±44.43 | 8.00±18.26 | 0.053 |
| AFP (ng/mL) | 3.95±2.01 | 3.10±1.97 | 0.010 |
| CA125 (U/mL) | 27.97±24.17 | 11.94±8.17 | 0.000 |
| CA199 (U/mL) | 62.15±117.85 | 33.82±110.92 | 0.133 |
| Colon cancer | 41 | 38 | 0.353 |
| Rectal cancer | 31 | 39 | |
| Left hemicolon cancer | 39 | 46 | 0.492 |
| Right hemicolon cancer | 33 | 31 |